Allies of Skin markets Copper Tripeptide & Ectoin Advanced Repair Serum as a cosmetic product subject to standard labeling requirements rather than FDA drug approval. This classification restricts permissible claims to cleansing, beautifying, promoting attractiveness, or altering appearance. The manufacturer’s disclosures place the formulation within the cosmetic category despite language referencing "skin recovery" and "compromised skin."
No New Drug Application, FDA monograph citation, or agency review specific to this formulation appears in available records. The product functions legally as a cosmetic. Labeling must therefore avoid therapeutic claims regarding disease treatment or structural repair.
Regulatory Classification and Product Identity
Allies of Skin serves as the named manufacturer and distributor. The product listing appears across U.S. retail channels including Nordstrom and Dermstore with a consistent 30 ml volume and $199 list price. Nordstrom describes the serum as a soothing repair formulation that helps restore balance and resilience to stressed or compromised skin (Nordstrom).
This positioning remains within cosmetic marketing boundaries. The serum "helps" rather than "treats." The National Eczema Association listing confirms product acceptance under that organization's directory but does not constitute FDA action (NEA). Readers tracking ingredient definitions may consult our guide on what are peptides for chemical basics or the types of peptides page for functional categorization relevant to this formulation.
Formulation Composition and Active Concentrations
Disclosed active complexes include four named ingredients with specified concentrations. Dermstore and Nordstrom list 2% Ectoin, 2% Copper Lysinate Complex, 2% Acetyl Hexapeptide-8 Complex, and 1% Copper Tripeptide Complex (Dermstore; Nordstrom). The full ingredient list shows Copper Tripeptide-1 appears alongside Copper Lysinate/Prolinate, Acetyl Hexapeptide-8, and supporting agents including Glycerin, Panthenol, Tocopherol, and Oxidized Glutathione.
The 1% disclosure for the copper tripeptide complex requires precise interpretation. The term "complex" indicates the figure applies to a blended input rather than pure Copper Tripeptide-1. A product audit notes this serum discloses two copper actives, which is uncommon in the category, and that the National Eczema Association seal requires safety documentation (MAXXING). Ingredient specifics for copper tripeptide 1 are covered separately in our dedicated guide.
Clinical Testing Parameters and Evidentiary Basis
Clinical claims derive from manufacturer-sponsored testing with defined parameters. Nordstrom reports a clinical self-assessment with 35 participants found 94% saw smoother skin with up to 33% less deep forehead wrinkles after twice-daily use for 28 days (Nordstrom). The same listing states a clinical test with 36 participants using instrumental analysis immediately after first application found 100% witnessed more hydrated skin.
LovelySkin reports that after one month, 40% of participants experienced less irritation, 89% saw improved skin quality, and 83% said their skin felt recovered (LovelySkin). Sample sizes remain small and most endpoints rely on self-reporting. Expert visual assessment using the Griffith's 10-point scale appears in disclosures, but underlying study design, blinding, control groups, and peer-review status are absent from retail or manufacturer sources.
The claim of "1.6x faster skin recovery in just 2 weeks" includes a footnote marker, yet the methodology is not reproduced in available records (Allies of Skin).
Third-Party Acceptance and Safety Designation
The National Eczema Association lists this serum in its product directory (NEA). Acceptance indicates the product met criteria for suitability for sensitive skin. It does not constitute a medical endorsement, treatment recommendation for eczema, or efficacy determination. The NEA product page uses manufacturer-supplied language including "clinically proven" phrasing and concentration disclosures, suggesting submitted content rather than independent evaluation.
Dermstore displays the Accepted National Eczema Association seal alongside a disclaimer stating result claims are based on clinical self-assessment with 35 participants (Dermstore). This designation addresses safety and tolerability for sensitive skin types rather than therapeutic outcomes.
Evidence Limits and Compliance Considerations
Source material for this formulation is restricted to commercial product pages, retailer listings, one non-profit product directory, and trade commentary. No FDA monograph, New Drug Application, peer-reviewed clinical trial, or independent laboratory analysis specific to this SKU appears in available records. All clinical percentages originate from manufacturer or retailer disclosures.
Regulatory professionals evaluating this product should request full test protocols, raw data, and stability documentation directly from Allies of Skin. The serum sits within a crowded field of popular peptides products combining GHK-Cu with supporting ingredients. The formulation strategy pairs a carrier peptide complex with an extremolyte and two additional peptide inputs. Whether that combination produces measurable advantage over Copper Tripeptide-1 alone remains unestablished by available evidence.
Evidence review recommended within 180 days. Product listings, concentration disclosures, and clinical test claims change without notice.

